Literature DB >> 25976929

Locally advanced anal canal carcinoma: is the addition of cetuximab the answer?

Francesca De Felice1, Daniela Musio2, Vincenzo Tombolini2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25976929     DOI： 10.1007/s00384-015-2243-5

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  4 in total

1.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

Authors: 
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

2.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

Authors:  H Bartelink; F Roelofsen; F Eschwege; P Rougier; J F Bosset; D G Gonzalez; D Peiffert; M van Glabbeke; M Pierart
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

3.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

4.  Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma.

Authors:  Luis O Olivatto; Fernando M Vieira; Bruno V Pereira; Ana P Victorino; Marcos Bezerra; Carlos M Araujo; Felipe Erlich; Lilian Faroni; Leonaldson Castro; Edward C Lusis; Alessandra Marins; Carlos Gil Ferreira
Journal:  Cancer       Date:  2013-05-14       Impact factor: 6.860
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.